Currently, there are various drugs available that target specific glioblastoma pathways (growth, invasion, migration) including but not limited to tyrosine kinase inhibitors (EGFR, mTOR, VEGF), NF-κB modulators, immunotherapeutics and nitrosoureas. This evidence concerns the gene VEGFA and glioblastoma.